In our study, the UGT1A1 variants (UGT1A1*6 and UGT1A1*28) and bilirubin level were not significantly associated with the risk of NAFLD in Han Chinese adult in Mendelian randomization trial. This evidence concerns the gene UGT1A1 and metabolic dysfunction-associated steatotic liver disease.